Clinically, ILC is associated with a higher age at diagnosis, a higher pathological T stage, a higher percentage of multifocal, multicentric and bilateral cases, a higher rate of estrogen receptor (ER) and PR-positivity, a lower histological grade and low tumour cell proliferation [5–10]. This evidence concerns the gene ESR1 and neoplasm.